Skip to content

Dario Jalilzadeh Masah

4 papers in the library · 17 citations · publishing 2021-2026

Papers

Sort Most recent Most cited

Persisting Psychological Complications Following the Use of Classic Psychedelics: A Qualitative Study of Help-Seeking Experiences

medRxiv Preprint Server May 23, 2026 Lisa Maria Jöbstl, Bente Lubahn, Ebru Kaya et al. preprint

Background While growing enthusiasm for the therapeutic potential of classic psychedelics has led to a rise in non-clinical use, attention to persisting adverse effects has emerged with delay. A subset of individuals reports persisting complications such as hallucinogen persisting perception disorder (HPPD), depersonalization/derealization disorder (DDD), anxiety and depression. Yet few medical...

Three Cases of Depersonalization/Derealization Disorder Related to the Use of Classic Psychedelics

SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice December 1, 2025 Dario Jalilzadeh Masah, Derin Marbin, Tomislav Majić 1 citation

Abstract: Aims: Symptoms of depersonalization (DP) and derealization (DR) are commonly reported during the acute effects of classic psychedelics. In some individuals, these symptoms persist, resulting in depersonalization-derealization disorder (DDD), associated with distress and help-seeking behavior. This case series seeks to underscore some of the diagnostic challenges and treatment...

No party, no drugs? Use of stimulants, dissociative drugs, and GHB/GBL during the early COVID-19 pandemic.

The International journal on drug policy April 1, 2022 Antonia Bendau, Leonard Viohl, Moritz Bruno Petzold et al.

The COVID-19 pandemic is presumably having an impact on the consumption of psychoactive substances. Social distancing and lockdown measures may particularly affect the use of "party drugs" (e.g., stimulants, dissociatives, and GHB/GBL) through the absence of typical use settings. We aimed to analyse the use patterns of those substances and underlying motivations before and during the pandemic....

Psychedelic Experiences During the Early COVID-19 Pandemic: Findings From an International Online Survey

Frontiers in Psychiatry November 4, 2021 Ricarda Evens, Simon Reiche, Roman M. Marek et al. 16 citations

Introduction: The current corona virus disease (COVID-19) pandemic has caused a serious global health crisis that has affected large parts of the public and private life worldwide, including the use of psychoactive substances. In this study, we investigated the effect of the COVID-19 pandemic on the use of serotonergic psychedelics, i.e., the settings in which people use psychedelics, the...